Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1995
06/15/1995WO1995015958A1 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
06/15/1995WO1995015957A1 Chroman derivative
06/15/1995WO1995015956A1 Bicyclic carboxylic acid leukotriene b4 antagonists
06/15/1995WO1995015954A1 Heterocyclic biphenylylamides useful as 5ht1d antagonists
06/15/1995WO1995015953A1 Novel substituted oxazolidines
06/15/1995WO1995015952A1 4,6-dianilino-pyrimidine derivatives, their preparation and their use as tyrosine kinase inhibitors
06/15/1995WO1995015951A1 Novel imidazole derivative and process for producing the same
06/15/1995WO1995015950A1 Compounds
06/15/1995WO1995015949A1 Tricyclic derivatives and their use in pharmaceuticals
06/15/1995WO1995015948A1 Novel 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof
06/15/1995WO1995015947A1 Anthracene spiro-pyrrolidines as immuno-modulators
06/15/1995WO1995015946A1 Piperazine-substituted pyrroloanthracene as immuno-moderators
06/15/1995WO1995015945A1 Substituted pyrroloanthracenes and pyrroloanthracene diones as immunomodulators
06/15/1995WO1995015939A1 Tricyclic derivatives, pharmaceutical compositions containing them
06/15/1995WO1995015761A1 Homeopathic solutions containing a nucleic acid
06/15/1995WO1995015760A1 Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
06/15/1995WO1995015759A1 A method of treating learning and memory disorders using benzothiadiazide derivatives as nootropic agents
06/15/1995WO1995015758A1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase
06/15/1995WO1995015757A1 Method of attenuating nerve injury induced pain
06/15/1995WO1995015756A1 Pharmaceutical formulation for preventing or pre-treating poisoning by organophosphoric cholinesterase inhibitors
06/15/1995WO1995015755A1 Transdermal therapeutical system for preventing poisoning by organophosphoric nurotoxins that consists of a combination of active substances including a parasympathomimetic and a parasympatholytic agent
06/15/1995WO1995015754A1 Transdermal delivery device
06/15/1995WO1995015753A1 Ovulation control by regulating nitric oxide levels
06/15/1995WO1995015752A1 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4
06/15/1995WO1995015751A1 Combined antipyretic analgesic drug
06/15/1995WO1995015750A1 Reducing likelihood of vascular disorders in susceptible patients
06/15/1995WO1995015749A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995WO1995014100A3 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting
06/15/1995WO1995014028A3 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
06/15/1995WO1995014014A3 Pyrone derivatives as protease inhibitors and antiviral agents
06/15/1995WO1995012678A3 Improvements relating to cancer therapy
06/15/1995WO1995009619A3 Substituted urea and isothiourea derivatives as no synthase inhibitors
06/15/1995CA2178634A1 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4
06/15/1995CA2178492A1 2-spiro(2'-spirocycloalkyl)cyclopropyl cephalosporin sulfones as antiinflammatory and antidegenerative agents
06/15/1995CA2178477A1 Pretargeting methods and compounds
06/15/1995CA2178100A1 Homeopathic solutions containing a nucleic acid
06/15/1995CA2177739A1 Novel 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof
06/15/1995CA2177588A1 Transdermal delivery device containing (s)-3methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole
06/15/1995CA2177495A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995CA2175701A1 Bicyclic heterocycles as neurokinin a antagonists
06/15/1995CA2155202A1 Bicyclic carboxylic acid leukotriene b4 antagonists
06/15/1995CA2137976A1 Thienothiazine derivatives
06/15/1995CA2137642A1 N-benzyl dihydroindole ltd4 antagonists
06/15/1995CA2137533A1 Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof
06/15/1995CA2137481A1 Process for the preparation of .alpha.-tocopherol derivatives
06/14/1995EP0657465A2 Liponucleotide compounds
06/14/1995EP0657464A1 9a-N-(N'-Carbamoyl) and 9a-N-(N'-Thiocarbamoyl) derivatives of 9-deoxo-9a-aza-9a-homoerythromycin A
06/14/1995EP0657459A1 Thienothiazine derivates, process for their preparation and their use as anti-inflammatory and analgesic agents
06/14/1995EP0657458A1 Protein kinase C inhibitors
06/14/1995EP0657456A1 Process for preparing epibatidine
06/14/1995EP0657455A1 Epi-epibatidine derivatives, a process and intermediates for preparing them and epi-epibatidine and medicaments containing the epi-epibatidine derivatives and/or epi-epibatidine and the use of them
06/14/1995EP0657454A1 Imidazopyridazines being angiotensin II antagonists
06/14/1995EP0657453A1 Angiotensin converting enzyme (ace) inhibitors containing a fused multiple ring lactam
06/14/1995EP0657452A1 Imidazopyridines
06/14/1995EP0657451A2 Pyrrolidine derivatives inhibitors of leukotriene biosynthesis
06/14/1995EP0657449A1 Azole compounds, their production and use as antifungal agents
06/14/1995EP0657448A1 One pot process for the preparation of 3-quinolonecarboxylic acid derivatives
06/14/1995EP0657443A1 Optically active carboxamide derivative
06/14/1995EP0657440A1 Oxazolidine-2-one derivatives
06/14/1995EP0657435A2 1,2-Dihydro-2-oxo-pyrimidines
06/14/1995EP0657434A1 Arylsubstituted -alkoxy-1,4-dihydropyridin-5-carbonic acid esters with cerebral activity
06/14/1995EP0657433A1 Dihydropyridines with substituted esters showing cerebral activity
06/14/1995EP0657432A1 Phenyl-substituted 1,4-dihydropyridines with cerebral activity
06/14/1995EP0657431A1 4-Phenyl-3-substituted 1,4-dihydropyridine esters with cerebral activity
06/14/1995EP0657430A1 Isopropyl-(2-methoxyethyl)-4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-piridine-3,5-dicarboxylate
06/14/1995EP0657428A1 Preparation of 3,4,4-trisubstitutedpiperidinyl-n-alkylcarboxylates and intermediates, useful as opioid antagonists
06/14/1995EP0657426A2 Tricyclic pyrrole derivatives
06/14/1995EP0657423A1 Aminosubstituted benzoylsulfonylurea and thiourea derivatives, process for their preparation and their use as pharmaceuticals
06/14/1995EP0657173A1 Endoparasiticide drugs on a basis of open chain hexadepsipeptides
06/14/1995EP0657172A1 Endoparasiticide drugs on a basis of open chain tetradepsipeptides
06/14/1995EP0657171A1 Endoparasiticide drugs on a basis of open chain octadepsipeptides
06/14/1995EP0657167A2 Use of oenotheine B for the manufacture of a medicament for the treatment of disorders related to hyperandrogenism, pharmaceutical compositions containing oenotheine B and a process for its preparation from epilobium parviflorum
06/14/1995EP0657166A1 Combination containing a quinoxaline and a nucleoside
06/14/1995EP0657165A1 Liver protectant composition
06/14/1995EP0657164A1 Pharmaceutical compositions containing staurosphorine derivatives
06/14/1995EP0657163A1 Antitussive
06/14/1995EP0657162A1 Methods for lowering serum cholesterol
06/14/1995EP0657161A1 Pharmaceutical granulate containing steroids
06/14/1995EP0657029A1 Calcium receptor active molecules
06/14/1995EP0656902A1 Peptide lung surfactants and therapeutic combinations
06/14/1995EP0656901A1 Fluorinated 6-methylenandrosta-1,4-dien-3-one derivatives and process for their preparation
06/14/1995EP0656900A1 Cationic-2-heteroarylphenyl-carbapenem antibacterial agents
06/14/1995EP0656899A1 Condensed carbapenem derivatives
06/14/1995EP0656897A1 Quinuclidine derivatives as squalene synthase inhibitors
06/14/1995EP0656890A1 Novel method for preparing ergothioneine
06/14/1995EP0656889A1 9-chloroprostaglandin esters and amides and their use in the preparation of drugs
06/14/1995EP0656888A1 Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
06/14/1995EP0656887A1 Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
06/14/1995EP0656881A1 Ester and combinations of an organic nitrate and a salicylate
06/14/1995EP0656844A1 Crank mechanism for a windscreen wiper drive of a motor vehicle.
06/14/1995EP0656795A1 Method for treating cardiovascular disease through adjunctive photodynamic therapy
06/14/1995EP0656791A1 Therapeutic compositions and methods using pqq
06/14/1995EP0656790A1 Compositions and methods for modulating rna
06/14/1995EP0656787A1 Method of inhibiting reduction of disulfide bonds
06/14/1995EP0656786A1 Health supplements containing phyto-oestrogens, analogues or metabolites thereof
06/14/1995EP0656782A1 Nutritional product for persons having a neurological injury
06/14/1995EP0656778A1 ENANTIOMERICALLY PURE $g(b)-D-DIOXOLANE-NUCLEOSIDES
06/14/1995EP0656777A1 Ready-to-inject azosemide solutions.
06/14/1995EP0656775A1 Sustained release tablets containing bupropion
06/14/1995EP0656774A1 Cosmetic and dermatological sunscreen compositions containing thiols and/or thiol derivates.
1 ... 7010 7011 7012 7013 7014 7015 7016 7017 7018 7019 7020 7021 7022 7023 7024 7025 7026 7027 7028 7029 7030 ... 7860